If you've ever faced nausea from chemotherapy or other challenging treatments, you may have heard of nabilone. This synthetic cannabinoid medicine resembles the active compounds found in cannabis but is manufactured under strict pharmaceutical controls. Despite increasing interest in cannabinoid medicines in the UK, access to nabilone on the NHS often raises questions. This article unpacks what nabilone is, how it fits into NHS prescribing, and what changed after the 2018 rescheduling.
What is Nabilone?
Nabilone is a man-made cannabinoid medicine developed to mimic tetrahydrocannabinol (THC), the main psychoactive component of cannabis. It is licensed in the UK primarily for treating chemotherapy-induced nausea and vomiting (CINV) when other antiemetic treatments have failed. The drug works by affecting the central nervous system receptors involved in nausea and vomiting.
Pharmaceutically, nabilone typically comes as capsules containing 1mg or 2mg doses, taken orally. Because it is a synthetic cannabinoid, it’s distinct from herbal cannabis or other plant-based cannabis extracts (like CBD oil).
The 2018 Rescheduling: What Changed?
Before 2018, nabilone and similar cannabinoid medicines were more tightly controlled under UK drug laws. The rescheduling in 2018 moved cannabinoid medicines such as nabilone from Schedule 1 (no recognised medical use) to Schedule 2 controlled drugs under the Misuse of Drugs Regulations.
This shift was significant because Schedule 2 status allows these medicines to be legally prescribed by specialist doctors within the NHS and private sector. However, this change did not automatically mean wide NHS availability or funding. Instead, it clarified the legal framework enabling doctors to prescribe and hospitals or pharmacies to dispense cannabinoid medicines like nabilone in controlled, clinical settings.
What Rescheduling Means in Plain English
- Doctors can now legally prescribe nabilone without breaking the law. Pharmacies and hospitals can legally supply it with proper documentation. The NHS only funds nabilone in very specific cases, meaning most patients won’t get automatic NHS prescriptions just because of this change.
When is Nabilone Used on the NHS?
On the NHS, nabilone’s licensed indication is quite narrow: it is prescribed primarily for nausea and vomiting caused by chemotherapy when other antiemetics have failed. This situation aligns with NICE guidance and hospital formularies that require specialist clinical judgment and careful assessment before approving treatment.
It’s important to separate two concepts that often get muddled:
Legal prescribing: Nabilone can be legally prescribed in the UK by specialist doctors. NHS funding: Even if it is legal to prescribe, the NHS does not always fund or provide the medicine routinely.In most cases, nabilone is prescribed and funded only by specialists working in oncology or palliative care teams where other anti-nausea treatments have been tried first without success.
Specialist-Only Prescribing Rules
Due to its controlled drug status and relatively narrow licensed use, nabilone can only be prescribed by consultant-level specialists—generally oncologists, palliative care consultants, or occasionally neurologists for certain indications.
General practitioners (GPs) or primary care doctors are not permitted to initiate or continue nabilone prescriptions unless under very specific shared care protocols, which are rare for cannabinoid medicines.
Unlicensed Cannabis-Based Medicines and NHS Caution
A growing trend in the UK is the use of unlicensed cannabis-based medicinal products (CBMPs), which include oils, sprays, and capsules derived directly from cannabis plants or combining multiple cannabinoids like THC and CBD.
The NHS remains cautious about funding these unlicensed products largely due to:
- Lack of large-scale, robust clinical trial data proving clear effectiveness and safety. Variability in product quality and formulation. Concerns about consistency and regulatory oversight.
Unlike licensed medicines like nabilone, these unlicensed CBMPs are rarely available on the NHS and often must be accessed privately through clinicians listed on directories such as medicalcannabis.co.uk. Resources like releaf.co.uk provide clear patient-friendly explanations about cannabinoid medicine options and legalities.
Pricing Considerations for Nabilone
No specific prices for nabilone on the NHS were clearly stated in the sources reviewed. Pricing can vary depending on supply contracts, hospital pharmacy agreements, and manufacturer pricing policies. If future reputable sources detail nabilone pricing, it is important to quote such figures exactly and state the source explicitly.
Generally, the cost for patients paying privately for synthetic cannabinoids like nabilone could be considerably higher than NHS-funded prescriptions, which complicates access for some who are not eligible for NHS funding.
Summary Table: Key Facts About Nabilone on the NHS
Aspect Details Drug Class Synthetic cannabinoid medicine Licensed Uses Chemotherapy-induced nausea and vomiting (when standard antiemetics fail) Legal Status Schedule 2 controlled drug (since 2018 rescheduling) Prescribing Specialist consultants only (oncology, palliative care) NHS Funding Restricted, specialist-approved, case-by-case basis Access to Unlicensed CBMPs Rarely NHS-funded; often private via specialist clinics (see medicalcannabis.co.uk)What This Means for Patients
For patients suffering chemo nausea where conventional antiemetics haven't worked, nabilone offered under NHS care may provide relief, but only if prescribed and closely monitored by specialists. It is not an over-the-counter or GP-initiated treatment.
If you are interested in cannabinoid medicines but do not qualify for NHS-funded nabilone, private clinics accredited on sites like medicalcannabis.co.uk can guide you. Always make sure to confirm legality, safety, and cost when considering private treatment.
Finally, remember that while the 2018 rescheduling made medicines like nabilone legally prescribable, it did not guarantee NHS funding or easy access. vergemagazine.co This distinction is crucial to understand when discussing cannabinoid medicine access in the UK.
Further Reading and Resources
- MedicalCannabis.co.uk — Clinic directory and comparison site for cannabinoid medicines. Releaf.co.uk — Explainers and patient-friendly guides on cannabinoid medicines in the UK. NICE Guidelines — For official NHS guidance on nausea and vomiting management.